Aug 4 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ANNOUNCES REVERSE STOCK SPLIT TO
REGAIN
COMPLIANCE WITH NASDAQ’S MINIMUM BID PRICE REQUIREMENT AND
REDUCE THE PUBLIC FLOAT
* ADIAL PHARMACEUTICALS INC ANNOUNCES 1 FOR 25 REVERSE STOCK
SPLIT
* ADIAL PHARMACEUTICALS INC - WILL EFFECT A 1-FOR-25 REVERSE
STOCK
SPLIT OF ITS COMMON STOCK THAT WILL BECOME EFFECTIVE ON AUGUST 4
Source text for Eikon: ID:nGNXch8SpV
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))